These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 28530524)

  • 41. Understanding Use of Real-World Data and Real-World Evidence to Support Regulatory Decisions on Medical Product Effectiveness.
    Mahendraratnam N; Mercon K; Gill M; Benzing L; McClellan MB
    Clin Pharmacol Ther; 2022 Jan; 111(1):150-154. PubMed ID: 33891318
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Optimization of Medication Use at Accountable Care Organizations.
    Wilks C; Krisle E; Westrich K; Lunner K; Muhlestein D; Dubois R
    J Manag Care Spec Pharm; 2017 Oct; 23(10):1054-1064. PubMed ID: 28944730
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Use of Real-World Evidence to Drive Drug Development Strategy and Inform Clinical Trial Design.
    Dagenais S; Russo L; Madsen A; Webster J; Becnel L
    Clin Pharmacol Ther; 2022 Jan; 111(1):77-89. PubMed ID: 34839524
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Variation in Private Payer Coverage of Rheumatoid Arthritis Drugs.
    Chambers JD; Wilkinson CL; Anderson JE; Chenoweth MD
    J Manag Care Spec Pharm; 2016 Oct; 22(10):1176-81. PubMed ID: 27668566
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Improving transparency to build trust in real-world secondary data studies for hypothesis testing-Why, what, and how: recommendations and a road map from the real-world evidence transparency initiative.
    Orsini LS; Monz B; Mullins CD; Van Brunt D; Daniel G; Eichler HG; Graff J; Guerino J; Berger M; Lederer NM; Jonsson P; Schneeweiss S; Wang SV; Crown W; Goettsch W; Willke RJ
    Pharmacoepidemiol Drug Saf; 2020 Nov; 29(11):1504-1513. PubMed ID: 32924243
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Medical abortion offered in pharmacy versus clinic-based settings.
    Rodriguez MI; Edelman A; Hersh A; Gartoulla P; Henderson J
    Cochrane Database Syst Rev; 2021 Jun; 6(6):CD013566. PubMed ID: 34114643
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Real-world evidence for coverage decisions: opportunities and challenges.
    Hampson G; Towse A; Dreitlein WB; Henshall C; Pearson SD
    J Comp Eff Res; 2018 Dec; 7(12):1133-1143. PubMed ID: 30411972
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Payer perceptions on the use of patient-reported outcomes in oncology decision making.
    Oderda G; Brixner D; Biskupiak J; Burgoyne D; Arondekar B; Deal LS; Quek RG; Niyazov A
    J Manag Care Spec Pharm; 2022 Feb; 28(2):188-195. PubMed ID: 34806908
    [No Abstract]   [Full Text] [Related]  

  • 49. A Comprehensive Framework for Evaluating the Value Created by Real-World Evidence for Diverse Stakeholders: The Case for Coordinated Registry Networks.
    Gressler LE; Marinac-Dabic D; Resnic FS; Williams S; Yang K; Weichold F; Avila-Tang E; Mack C; Coplan P; Panagiotou OA; Pappas G
    Ther Innov Regul Sci; 2024 Jul; ():. PubMed ID: 39060838
    [TBL] [Abstract][Full Text] [Related]  

  • 50. AMCP Partnership Forum: Digital Therapeutics-What Are They and Where Do They Fit in Pharmacy and Medical Benefits?
    J Manag Care Spec Pharm; 2020 May; 26(5):674-681. PubMed ID: 32175784
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Outcomes-Based Contracting Experience: Research Findings from U.S. and European Stakeholders.
    Nazareth T; Ko JJ; Sasane R; Frois C; Carpenter S; Demean S; Vegesna A; Wu E; Navarro RP
    J Manag Care Spec Pharm; 2017 Oct; 23(10):1018-1026. PubMed ID: 28944734
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Use of Healthcare Claims Data to Generate Real-World Evidence on Patients With Drug-Resistant Epilepsy: Practical Considerations for Research.
    Stamas N; Vincent T; Evans K; Li Q; Danielson V; Lassagne R; Berger A
    J Health Econ Outcomes Res; 2024; 11(1):57-66. PubMed ID: 38425708
    [No Abstract]   [Full Text] [Related]  

  • 53. Real world evidence (RWE) - a disruptive innovation or the quiet evolution of medical evidence generation?
    Khosla S; White R; Medina J; Ouwens M; Emmas C; Koder T; Male G; Leonard S
    F1000Res; 2018; 7():111. PubMed ID: 30026923
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Meeting the affordability challenges posed by orphan drugs: a survey of payers, providers, and employers.
    Lopata E; Terrone C; Gopalan A; Ladikos N; Richardson T
    J Manag Care Spec Pharm; 2021 Jun; 27(6):706-713. PubMed ID: 33586514
    [No Abstract]   [Full Text] [Related]  

  • 55. The availability of references and the sponsorship of original research cited in pharmaceutical advertisements.
    Cooper RJ; Schriger DL
    CMAJ; 2005 Feb; 172(4):487-91. PubMed ID: 15710940
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Characterizing health plan evidence review practices.
    Panzer AD; Enright DE; Graff J; Chambers JD
    J Manag Care Spec Pharm; 2022 Sep; 28(9):1053-1058. PubMed ID: 36001106
    [No Abstract]   [Full Text] [Related]  

  • 57. The Case for Real-world Evidence in the Future of Clinical Research on Chronic Myeloid Leukemia.
    Webster J; Smith BD
    Clin Ther; 2019 Feb; 41(2):336-349. PubMed ID: 30709609
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Estimated Cost-Effectiveness, Cost Benefit, and Risk Reduction Associated with an Endocrinologist-Pharmacist Diabetes Intense Medical Management "Tune-Up" Clinic.
    Hirsch JD; Bounthavong M; Arjmand A; Ha DR; Cadiz CL; Zimmerman A; Ourth H; Morreale AP; Edelman SV; Morello CM
    J Manag Care Spec Pharm; 2017 Mar; 23(3):318-326. PubMed ID: 28230459
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impact of a Patient Support Program on Patient Adherence to Adalimumab and Direct Medical Costs in Crohn's Disease, Ulcerative Colitis, Rheumatoid Arthritis, Psoriasis, Psoriatic Arthritis, and Ankylosing Spondylitis.
    Rubin DT; Mittal M; Davis M; Johnson S; Chao J; Skup M
    J Manag Care Spec Pharm; 2017 Aug; 23(8):859-867. PubMed ID: 28737994
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.